O Ohr Pharmaceutical Inc: management transactions · United States · SEC (Form 4) Browse the full management transaction log of Ohr Pharmaceutical Inc, a publicly traded company based in United States. Shares are listed on US US, under the authority of SEC (Form 4). The latest transaction was reported on 20 January 2016 (Acquisition). Among the most active insiders: Slakter Jason Scott. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Last declaration on 20 January 2016
All Executives20 Thresholds0 Prospectus0 Other0
Declarations 20 total
▲ Chief Executive Officer · Executives · 19 Jan 2016
100 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:0
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
200 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:1
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
500 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:2
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
400 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:3
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
200 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:4
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
100 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:5
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
200 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:6
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
200 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:7
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
200 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:8
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
200 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:9
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
400 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:10
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
100 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:11
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
100 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:12
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
850 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:13
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
1,200 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:14
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
1,000 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:15
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
100 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:16
Ideal exit: 15 Oct 2016 (T+270) ▲ Chief Executive Officer · Executives · 19 Jan 2016
200 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003930:17
Ideal exit: 15 Oct 2016 (T+270) ◆ Chief Financial Officer · Executives · 7 Jan 2016
130,000 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003869:0
◆ Chief Executive Officer · Executives · 7 Jan 2016
350,358 shares Common Stock, par value $0.0001 per share SEC:0001387131-16-003867:0